Ticagrelor
Description
Ticagrelor is a potent antiplatelet medication prescribed to prevent blood clots in individuals with a high risk of cardiovascular events. It works by blocking the P2Y12 receptor on platelets, inhibiting their ability to clump together and form clots. Ticagrelor is commonly used after a heart attack, stroke, or in patients with unstable angina to reduce the risk of future events. It is typically taken in tablet form, twice a day, and is generally well-tolerated. However, like all medications, it can have side effects, including bleeding, and potential interactions with other drugs.
Associated Diseases
- Coronary artery disease
- Acute coronary syndrome
- Peripheral artery disease
- Stroke
- Atrial fibrillation
- Heart valve replacement
Did you know?
Ticagrelor was the first oral P2Y12 inhibitor approved by the FDA for the prevention of cardiovascular events.
